Olivier George Selected Research

Biomarkers (Surrogate Marker)

1/2024	Antagonists of the stress and opioid systems restore the functional connectivity of the prefrontal cortex during alcohol withdrawal through divergent mechanisms.
5/2021	The Cocaine and Oxycodone Biobanks, Two Repositories from Genetically Diverse and Behaviorally Characterized Rats for the Study of Addiction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Olivier George Research Topics

Disease

16	Tobacco Use Disorder (Nicotine Dependence) 04/2024 - 07/2010
11	Alcoholism (Alcohol Abuse) 03/2024 - 10/2012
8	Hyperalgesia 10/2023 - 01/2015
7	Body Weight (Weight, Body) 04/2024 - 01/2017
7	Cocaine-Related Disorders (Cocaine Addiction) 11/2023 - 04/2009
7	Opioid-Related Disorders (Opiate Addiction) 10/2023 - 12/2013
6	Substance-Related Disorders (Drug Abuse) 08/2023 - 01/2018
6	Substance Withdrawal Syndrome (Withdrawal Symptoms) 03/2023 - 12/2013
2	Neuroinflammatory Diseases 06/2023 - 07/2014
2	Inflammation (Inflammations) 11/2020 - 01/2020
2	Pain (Aches) 05/2020 - 01/2015
2	Hypersensitivity (Allergy) 01/2018 - 01/2015
1	Type 2 Diabetes Mellitus (MODY) 11/2023
1	Respiratory Insufficiency (Respiratory Failure) 10/2023
1	Morphine Dependence 05/2023
1	Amphetamine-Related Disorders (Addiction, Amphetamine) 05/2023
1	Drug Overdose 01/2022
1	Food Addiction 01/2020
1	Disease Progression 01/2020
1	Chronic Pain 01/2020
1	Weight Gain 01/2018
1	Heroin Dependence (Heroin Abuse) 08/2017
1	Mental Disorders (Mental Disorder) 01/2017
1	Acute Pain 01/2017
1	Parkinson Disease (Parkinson's Disease) 07/2014
1	Huntington Disease (Huntington's Disease) 07/2014
1	Gliosis 07/2014
1	Neurocognitive Disorders (Clerambault Syndrome) 07/2014
1	HIV Infections (HIV Infection) 07/2014

Drug/Important Bio-Agent (IBA)

22	Nicotine FDA Link 04/2024 - 07/2010
7	Opioid Analgesics (Opioids)IBA 01/2022 - 04/2009
4	Oxycodone (Oxycontin)FDA LinkGeneric 10/2023 - 01/2019
4	Cocaine (Cocaine HCl)IBA 06/2023 - 01/2018
4	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 03/2023 - 02/2011
4	Ethanol (Ethyl Alcohol)IBA 01/2023 - 04/2009
3	LeptinIBA 11/2023 - 01/2020
3	Analgesics (Analgesic Drugs)IBA 10/2023 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 01/2024 - 05/2021
2	Cholinergic Agents (Cholinergics)IBA 03/2023 - 01/2023
2	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2022 - 01/2021
2	Corticotropin-Releasing HormoneIBA 01/2020 - 01/2017
2	CannabinoidsIBA 01/2018 - 04/2009
2	Naloxone (Narcan)FDA LinkGeneric 01/2018 - 01/2017
2	Heroin (Diamorphine)IBA 08/2017 - 12/2013
2	Dynorphins (Dynorphin)IBA 01/2014 - 12/2013
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 03/2024
1	R 121919IBA 01/2024
1	mu Opioid Receptors (mu Opioid Receptor)IBA 01/2024
1	Naltrexone (ReVia)FDA LinkGeneric 01/2024
1	Insulin (Novolin)FDA Link 11/2023
1	GhrelinIBA 11/2023
1	Hormones (Hormone)IBA 11/2023
1	ChromatinIBA 11/2023
1	MicroRNAs (MicroRNA)IBA 05/2023
1	Nerve Growth Factors (Neurotrophins)IBA 05/2023
1	BenzodiazepinesIBA 01/2023
1	Adrenergic Antagonists (Antiadrenergic Agents)IBA 01/2023
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2022
1	CannabidiolIBA 08/2021
1	paraform (paraformaldehyde)IBA 05/2021
1	Dopamine (Intropin)FDA LinkGeneric 11/2020
1	Cannabinoid Receptor AgonistsIBA 11/2020
1	Phosphotransferases (Kinase)IBA 11/2020
1	Caffeine (No Doz)FDA LinkGeneric 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2020
1	VK4-116IBA 01/2019
1	Dopamine D3 ReceptorsIBA 01/2019
1	EnzymesIBA 10/2018
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 05/2018
1	OrexinsIBA 01/2018
1	A-factor (Streptomyces)IBA 01/2018
1	Sufentanil (Sufenta)FDA LinkGeneric 01/2018
1	Therapeutic UsesIBA 08/2017
1	Messenger RNA (mRNA)IBA 01/2017
1	NociceptinIBA 01/2017
1	LipopolysaccharidesIBA 01/2017
1	Peptides (Polypeptides)IBA 01/2017
1	Opioid Receptors (Opioid Receptor)IBA 01/2017
1	6'- fluoro- 4',9'- dihydro- N,N- dimethyl- 4- phenylspiro(cyclohexane- 1,1'(3'H)- pyrano(3,4- b)indol)- 4- amineIBA 01/2017
1	Calcium Channels (Calcium Channel)IBA 01/2017
1	Mifepristone (RU 486)FDA Link 08/2015
1	CRF receptor type 1IBA 01/2015
1	Prostaglandin D2IBA 07/2014
1	Proteins (Proteins, Gene)FDA Link 07/2014
1	InterferonsIBA 07/2014
1	NetrinsIBA 07/2014
1	prostaglandin R2 D-isomerase (prostaglandin D2 synthase)IBA 07/2014
1	Opiate AlkaloidsIBA 12/2013
1	Illicit Drugs (Recreational Drugs)IBA 12/2013
1	gamma-Aminobutyric Acid (GABA)IBA 10/2012
1	Varenicline (Chantix)FDA Link 02/2011
1	EndocannabinoidsIBA 04/2009

Therapy/Procedure

16	Self Administration (Administration, Self) 10/2023 - 02/2011
3	Therapeutics 01/2019 - 08/2017
1	Secondary Prevention 08/2023
1	Pain Management 01/2019
1	Biological Therapy 10/2018
1	Deep Brain Stimulation 08/2017